Clinical Trial

Role of Amlodipine in Reduction of CIN

Name: Role of Amlodipine in Reduction of CIN — clinical trial record (NCT07291375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated December 18, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit

Trial Details

NCT Number	NCT07291375
Lead Sponsor	Minia University
Conditions	Contrast-induced Nephropathy
Enrollment	40 participants
Start Date	2025-12-20
Primary Completion	2026-06-01 (estimated)
Study Completion	2026-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-18